Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005.
Lantibiotics are ribosomally synthesized oligopeptide antibiotics that contain lanthionine bridges derived by the posttranslational modification of amino acid residues. Here, we describe the cinnamycin biosynthetic gene cluster (cin) from Streptomyces cinnamoneus cinnamoneus DSM 40005, the first, to our knowledge, lantibiotic gene cluster from a high G+C bacterium to be cloned and sequenced. The cin cluster contains many genes not found in lantibiotic clusters from low G+C Gram-positive bacteria, including a Streptomyces antibiotic regulatory protein regulatory gene, and lacks others found in such clusters, such as a LanT-type transporter and a LanP-type protease. Transfer of the cin cluster to Streptomyces lividans resulted in heterologous production of cinnamycin. Furthermore, modification of the cinnamycin structural gene (cinA) led to production of two naturally occurring lantibiotics, duramycin and duramycin B, closely resembling cinnamycin, whereas attempts to make a more widely diverged derivative, duramycin C, failed to generate biologically active material. These results provide a basis for future attempts to construct extensive libraries of cinnamycin variants.
Widdick
D A
DA
Department of Molecular Microbiology, John Innes Centre, Colney Lane, Norwich, Norfolk NR4 7UH, United Kingdom.
Dodd
H M
HM
Barraille
P
P
White
J
J
Stein
T H
TH
Chater
K F
KF
Gasson
M J
MJ
Bibb
M J
MJ
D000900:Anti-Bacterial Agents / Q000096:biosynthesis*; D001430:Bacteriocins; D001483:Base Sequence; D001665:Binding Sites; D003001:Cloning, Molecular; D008969:Molecular Sequence Data; D005810:Multigene Family; D010456:Peptides, Cyclic; D010957:Plasmids; D015183:Restriction Mapping; D013045:Species Specificity; D013302:Streptomyces / Q000235:genetics*
D000900:Anti-Bacterial Agents; D001430:Bacteriocins; D010456:Peptides, Cyclic; C000485:cinnamycin